Skip to content

Falcon's Beyond Global FBYD Cost Of Product Sales

Cost Of Product Sales at other companies

Kura Oncology logo
Kura OncologyKURA
$14.25K
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$30M+3.4%
Trimble Inc. logo
Trimble Inc.TRMB
$158.2M+10.1%
Textron logo
TextronTXT
$2.62B+15.2%
Motorola Solutions, Inc. logo
Motorola Solutions, Inc.MSI
$629M+9.8%
Axon Enterprise, Inc. logo
Axon Enterprise, Inc.AXON
$232.16M+36.4%

Segments

By segment

See full
Reportable Segments$1.58M

Other financials

Income statement

See full
Revenue$5.4M+215%
Operating income$6.5M+202%
Net income$3.1M+185%
EPS (diluted)$0.05+138%

Balance sheet

See full
Cash & equivalents$1.2M+6.1%
Total debt$10.5M-73.2%
Total equity$14.9M+229%
Total assets$62.4M+9.9%

Cash flow

See full
Operating cash flow-$2.8M-391%
CapEx$12.0K-87.0%
Free cash flow-$2.8M-424%

Valuation

See full
Market cap$848.4M+309%
Enterprise value$857.7M+250%
P/E47.7×+43.0×
P/S45.7×+15.8×

Profitability

See full
Operating margin-3.1%-1.6pp
Net margin95.7%-534pp
FCF margin-152.8%+77.2pp

Returns & leverage

See full
Return on equity-36.2%
Debt / equity0.7×
Current ratio0.4×+0.4×

Where this comes from

Reported directly by Falcon's Beyond Global in its filing.

Tagged under the XBRL concept fbyd:CostOfProductSales.

The official record: Falcon's Beyond Global’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Falcon's Beyond Global's cost of product sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Falcon's Beyond Global's cost of product sales?
Falcon's Beyond Global (FBYD) reported cost of product sales of $394.75K in Q4 2025.
What does cost of product sales mean?
Refers to the direct costs attributable to the production and delivery of physical goods or merchandise sold by the company. This includes materials, labor, and overhead directly tied to product manufacturing. It is a key indicator of the company's ability to manage production costs relative to its product-based revenue streams.